Washington. US President Donald Trump announced on Wednesday that America will impose heavy import duties (tariffs) on generic medicines imported from abroad from August 2028. He said that the purpose of this step is to produce generic medicines within America. This decision may impact India, because India is the largest exporter of generic medicines to America.
Trump said on the Truth social platform that from August 1, 2026, the tariff on all generic drugs coming into America will remain zero percent for the next two years. After this it will be increased to 100 percent for one year. After that it will be increased to 200 percent.
What did Trump say?
US President Donald Trump said that from August 1, 2026, there will be zero percent import duty on all generic medicines brought into America for the next two years. After this it will be 100 percent for one year and after that it will be increased to 200 percent.
He said that this decision has been taken so that the production of generic medicines starts again in America. He said that companies who do not set up factories and necessary equipment in America within the stipulated time will have to face penalties under this policy.
What will change in the new policy?
President Trump said that the purpose of this policy is to protect the interests of the American people. He also said that there will be no change in the existing policy related to patented, branded and new medicines and it will continue as before.
How much does India export medicines to America?
According to a report by Global Trade Research Initiative (GTRI), India is expected to export medicines worth US$ 9.7 billion to the US in the year 2025. This was 36 percent of India’s total global pharmaceutical exports of US$25.8 billion.
Where are generic medicines used?
Generic medicines made in India are widely used in the treatment of high blood pressure, diabetes, cancer, infectious diseases and mental health related diseases.
Comments are closed.